Efficacy and safety of percutaneous coronary intervention in acute coronary syndrome patients randomized to enoxaparin or unfractionated heparin: Results of SYNERGY

被引：0
|
作者：
White, HD
Kleiman, NS
Chew, D
Petersen, JL
Berdan, LG
Traylor, L
Mahaffey, KW
Cohen, M
Santos, R
Harrington, RA
Califf, RM
Ferguson, JJ
机构：
[1] Green Lane Hosp, Auckland 3, New Zealand
[2] Duke Univ, Clin Res Inst, Durham, NC USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61A / 61A
页数：1
相关论文
共 50 条
  • [41] A meta-analysis of bivalirudin compared with unfractionated heparin in patients with acute coronary syndromes undergoing urgent percutaneous coronary intervention versus elective percutaneous coronary intervention
    Liu, Yulong
    Li, Liang
    Wang, Mei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C111 - C111
  • [42] Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS)
    Bertel, Osmund
    Ramsay, David
    Wettstein, Tobias
    Kurz, David J.
    Stettler, Irene
    Straumann, Edwin
    Frielingsdorf, Juergen
    Maurer, Dominik
    Naegeli, Barbara
    EUROINTERVENTION, 2010, 6 (03) : 407 - 412
  • [43] Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
    Graca Santos, L.
    Ribeiro Carvalho, R.
    Montenegro, F.
    Ruivo, C.
    Correia, J.
    Pernencar, S.
    Soares, F.
    Morais, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1893 - 1893
  • [44] A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)
    Collet, Jean-Philippe
    Huber, Kurt
    Cohen, Marc
    Zeymer, Uwe
    Goldstein, Patrick
    Pollack, Charles, Jr.
    Silvain, Johanne
    Henry, Patrick
    Varenne, Olivier
    Carrie, Didier
    Coste, Pierre
    Angioi, Michael
    Le Breton, Herve
    Cayla, Guillaume
    Elhadad, Simon
    Teiger, Emmanuel
    Filippi, Emmanuelle
    Aout, Mounir
    Vicaut, Eric
    Montalescot, Gilles
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (09): : 1367 - 1372
  • [45] Comparing full dose & half dose enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
    Abd El Kader, M.
    Saleh, A.
    Gomaa, Y.
    Morttada, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 582 - 582
  • [46] Enoxaparin is noninferior to unfractionated heparin in patients with non-ST elevation acute coronary syndrome treated with the use of early invasive strategy.: Results of SYNERGY Trial
    Gratsianskii, NA
    KARDIOLOGIYA, 2004, 44 (05) : 77 - 79
  • [47] Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa inhibitors (SYNERGY) trial (vol 152, pg 1042, 2006)
    White, H. D.
    AMERICAN HEART JOURNAL, 2007, 153 (02) : 327 - 327
  • [48] Safety and Effectiveness of Rivaroxaban in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention
    Li Xiaoyan
    Lu Ying
    Zhang Er Hong
    Zhang Ping
    Zhang Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C150 - C150
  • [49] Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome
    Cruz-Gonzalez, Ignacio
    Sanchez-Ledesma, Maria
    Baron, Suzanne J.
    Healy, Josephine L.
    Watanabe, Hikari
    Osakabe, Masanori
    Yeh, Robert W.
    Jang, Ik-Kyung
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (02) : 214 - 218
  • [50] Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome
    Ignacio Cruz-Gonzalez
    Maria Sanchez-Ledesma
    Suzanne J. Baron
    Josephine L. Healy
    Hikari Watanabe
    Masanori Osakabe
    Robert W. Yeh
    Ik-Kyung Jang
    Journal of Thrombosis and Thrombolysis, 2008, 25 : 214 - 218
12345